First State-Backed CBD Conference in Israel

Israel is hosting the first government-backed medical cannabis conference called Cannaan at Kfar Hamaccabiah in Ramat Gan. Cannaan is a combination of two words: Cannabis and Canaan (a region of Israel). The four-day conference is an initiative of the Ministries of Agriculture and Health to generate awareness about medical cannabis.

The conference will commence with a welcome note and speech by the Israeli Minister of Agriculture, Uri Ariel. The second day will start with opening remarks from Yuval Landshaft, Head of Israeli Medical Cannabis Agency at the Ministry of Health. The main session will start with an overview of the Endocannabinoid System by Professor Emeritus Raphael Mechoulam, Director of Medical Cannabis Research.

The next two days will feature more talks on research in phytocannabinoids, medicalization, and regulations in Israel. Additionally, the keynote speakers will talk about hi-tech agriculture, clinical studies, and cannabis-based medicines.

The country is awaiting a final decision from the Israeli Cabinet to export medical cannabis. A decision is expected in the next few weeks. The conference is organized to promote medical cannabis and the rapidly emerging industry.

Israel was one of the first nations to approve the medicinal use of cannabis in 1990 to treat various diseases. In the past few years, the country has witnessed an increase in the use of the plant. In addition to this, biotech companies have made significant advancements in deriving non-psychoactive cannabidiol from hemp. As a result, the plant’s therapeutic features can be used to treat a number of diseases.

Despite being the first nation to make medical cannabis legal, Israel is still waiting for approval to export it. However, the Knesset Economics Committee and the Ministries of Agriculture and Health see promising growth potential through exports. Moreover, the rising demand for pharmaceutical-grade cannabidiol in Israel and the rest of the world is pushing the industry to thrive.


Read more: ‘CBD: The Biotech Boom Investors Haven’t Woken Up To Yet’

Leave a Reply

Your email address will not be published.